Australia - engleză - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - cytarabine, quantity: 2 g - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - primarily for induction and maintenance of remission in acute myelocytic leukaemia of both adults and children. it has also been found to be useful in the treatment of other leukaemias such as acute lymphocytic leukaemia, chronic myelocytic leukaemia (blastphase) and erythroleukaemia. may be used alone or in combination with other antineoplastic agents, the best results often being obtained with combination therapy. children with non-hodgkin's lymphoma have benefited from a combination drug program (lsa 2l2) that includes cytarabine. indications as at 24 october 2001: cytarabine is indicated primarily for: induction and maintenance of remission in acute myelocytic leukaemia of both adults and children. it has also been found to be useful in the treatment of other leukaemias such as acute lymphocytic leukaemia, chronic myelocytic leukaemia (blast phase). cytarabine may be used alone or in combination with other antineoplastic agents, the best results are often obtained with combined therapy. children with non-hodgkin's lymphoma have benefited from a combination drug program (lsa212) that includes cytarabine. remissions induced by cytarabine not followed by maintenance treatment have been brief. maintenance therapy has extended these and provided useful and comfortable remissions with relatively little toxicity. cytarabine has been used intrathecally in meningeal leukaemia. focal leukaemic involvement of the central nervous system may not respond to intrathecal cytarabine and may better be treated with radiotherapy.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

celltrion healthcare australia pty ltd - podophyllotoxin, quantity: 5 mg/ml - solution - excipient ingredients: ethanol; (s)-lactic acid; sodium (s)-lactate; purified water - for the treatment of anogenital warts.

Australia - engleză - APVMA (Australian Pesticides and Veterinary Medicines Authority)

imtrade australia pty ltd - fipronil - water dispersible granule - fipronil nitrile active 800.0 g/kg - insecticide - banana | brassica vegetables | broccoli | brussels sprouts | cabbage | cauliflower | cotton | grape - wine | pasture | potato | - australian plague locust | banana rust thrip | banana weevil borer | cabbage cluster caterpillar | cabbage moth | cabbage white butterfly | fig longicorn | green mirid bug | migratory locust | mole cricket | onion or cotton seedling thrips | spur-throated locust | sugarcane weevil borer | sugarcane wireworm | white fringed weevil | wingless grasshopper | wireworm | cotton seedling thrips | cotton thrips | diamondback moth | dihammus vastator | naupactus leucoloma | nomadacris guttulosa | onion thrips

Australia - engleză - Department of Health (Therapeutic Goods Administration)

neo health (otc) pty ltd - ibuprofen, quantity: 200 mg - capsule, soft - excipient ingredients: gelatin; partially dehydrated liquid sorbitol; macrogol 600; fast green fcf; medium chain triglycerides; potassium hydroxide; titanium dioxide; hypromellose; propylene glycol; purified water; isopropyl alcohol - for the temporary relief of acute pain where inflammation is present such as back, neck and muscle pain. temporary relief of headache, migraine, period pain, dental pain, sore throat, arthritis pain and pain associated with cold and flu. reduces fever.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

neo health (otc) pty ltd - sodium bicarbonate, quantity: 378 mg; citric acid, quantity: 672 mg; potassium chloride, quantity: 149 mg (equivalent: potassium, qty 78 mg); sodium chloride, quantity: 87.5 mg; glucose, quantity: 1.62 g - tablet, effervescent - excipient ingredients: purified water; povidone; mannitol; purified talc; sucralose; macrogol 6000; flavour; colour - decrease/reduce/relieve symptoms of dehydration ; maintain/support body electrolyte balance ; helps restore body electrolyte balance ; helps decrease/reduce/relieve symptoms of traveller's diarrhoea ; helps decrease/reduce/relieve symptoms of occasional hangovers

Australia - engleză - Department of Health (Therapeutic Goods Administration)

neo health (otc) pty ltd - ibuprofen, quantity: 400 mg - tablet, film coated - excipient ingredients: allura red ac aluminium lake; titanium dioxide; povidone; macrogol 6000; maize starch; purified talc; colloidal anhydrous silica; sodium starch glycollate type a; croscarmellose sodium; hypromellose; magnesium stearate - the temporary relief of pain (and discomfort) associated with headache, migraine headache, tension headache, sinus pain, toothache, dental procedures, backache, muscular aches and pains, period pain, sore throat, tennis elbow, arthritis, rheumatic pain and the aches and pains associated with colds and flu. reduces fever.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

neo health (otc) pty ltd - citric acid, quantity: 672 mg; potassium chloride, quantity: 149 mg (equivalent: potassium, qty 78 mg); sodium bicarbonate, quantity: 378 mg; sodium chloride, quantity: 87.5 mg; glucose, quantity: 1.62 g - tablet, effervescent - excipient ingredients: macrogol 6000; purified water; sucralose; mannitol; purified talc; povidone; flavour - decrease/reduce/relieve symptoms of dehydration ; maintain/support body electrolyte balance ; helps restore body electrolyte balance ; helps decrease/reduce/relieve symptoms of traveller's diarrhoea ; helps decrease/reduce/relieve symptoms of occasional hangovers

Australia - engleză - Department of Health (Therapeutic Goods Administration)

neo health (otc) pty ltd - glucose, quantity: 1.62 g; potassium chloride, quantity: 149 mg (equivalent: potassium, qty 78 mg); citric acid, quantity: 672 mg; sodium bicarbonate, quantity: 378 mg; sodium chloride, quantity: 87.5 mg - tablet, effervescent - excipient ingredients: purified talc; purified water; macrogol 6000; sucralose; mannitol; povidone; flavour; colour - decrease/reduce/relieve symptoms of dehydration ; maintain/support body electrolyte balance ; helps restore body electrolyte balance ; helps decrease/reduce/relieve symptoms of traveller's diarrhoea ; helps decrease/reduce/relieve symptoms of occasional hangovers

Australia - engleză - Department of Health (Therapeutic Goods Administration)

bristol-myers squibb australia pty ltd - abatacept, quantity: 125.875 mg - injection - excipient ingredients: dibasic sodium phosphate; nitrogen; water for injections; sucrose; poloxamer; monobasic sodium phosphate - orencia in combination with methotrexate is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have had an insufficient response or intolerance to other disease modifying anti-rheumatic drugs (dmards), such as methotrexate or tumour necrosis factor (tnf) blocking agents. a reduction in the progression of joint damage and improvement in physical function have been demonstrated during combination treatment with orencia and methotrexate.,orencia in combination with methotrexate is also indicated in the treatment of severe, active and progressive rheumatoid arthritis in adults not previously treated with methotrexate.,orencia is indicated for reducing signs and symptoms in paediatric patients 6 years of age and older with moderately to severely active polyarticular juvenile idiopathic arthritis who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs (dmards). orencia may be used as monotherapy or concomitantly with methotrexate (mtx). (there is no clinical trial data for the use of orencia subcutaneous formulation in children, therefore its use in children cannot be recommended.),orencia is indicated for the treatment of active psoriatic arthritis (psa) in adults when the response to previous disease-modifying anti-rheumatic drug (dmard) therapy has been inadequate. orencia can be used with or without non-biologic dmards.,orencia should not be administered concurrently with other biological dmards (eg, tnf inhibitors, rituximab, or anakinra).

Australia - engleză - Department of Health (Therapeutic Goods Administration)

neo health (otc) pty ltd - naproxen sodium, quantity: 275 mg - capsule, soft - excipient ingredients: brilliant blue fcf; propylene glycol; purified water; partially dehydrated liquid sorbitol; lactic acid; povidone; glycerol; macrogol 600; gelatin; titanium dioxide; butan-1-ol; isopropyl alcohol; strong ammonia solution; simethicone; ethanol; shellac; sulfuric acid - for the relief of symptoms associated with periods, such as pain from menstrual cramps (i.e. symptomatic treatment of primary dysmenorrhoea).